PIERIS PHARMACEUTICALS INC (PIRS) Stock News
NASDAQ:PIRS - Nasdaq - US7207952026 - Common Stock - Currency: USD
PIRS Latest News, Press Releases and Analysis
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, ACNB, PIRS, OBDE on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, BRKH, PIRS, CFB on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment banking at Goldman Sachs
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AFBI, ENV, PIRS, BALY on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of Shareholders
PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q2 2024
Pieris Pharmaceuticals just reported results for the second quarter of 2024.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIRS, EMLD, ACNB, GLXZ on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.
/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and its board of directors...
Shareholder Alert: Ademi LLP investigates whether Pieris Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders
/PRNewswire/ -- Ademi LLP is investigating Pieris (Nasdaq: PIRS) for possible breaches of fiduciary duty and other violations of law in its transaction with...
ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split
Allarity Therapeutics stock is up on Wednesday as the company pushes ALLR investors to vote in favor of a reverse stock split.
Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today?
Pieris Pharmaceuticals stock is up on Wednesday as PIRS investors learn of the company preparing for a merger with Palvella Therapeutics.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement
PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q1 2024
Pieris Pharmaceuticals just reported results for the first quarter of 2024.
PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pieris Pharmaceuticals (NASDAQ:PIRS) just reported results for the first quarte...
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to close out this week of trading with an overview of the biggest pre-market stock movers to watch Friday morning!